ETFOther ETFsVery High

ICICI Prudential Nifty Pharma ETF

Q: What is the NAV of ICICI Prudential Nifty Pharma ETF?

As of 27 Oct 2026, the NAV of ICICI Prudential Nifty Pharma ETF is ₹26.25 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

Q: What returns has ICICI Prudential Nifty Pharma ETF delivered?

ICICI Prudential Nifty Pharma ETF has returned +1.91% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

Q: How risky is ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF sits at the very high level on our estimate of SEBI's risk-o-meter scale and its worst peak-to-trough fall in our sample was 0.0%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

Q: What is the benchmark of ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF is benchmarked against the Nifty Pharma TRI is. The alpha, beta and capture figures on this page are measured against the Nifty Pharma TRI, the closest index whose daily history we hold.

Q: Who manages ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF is managed by Nishit Patel, Ashwini Shinde and Venus Ahuja at ICICI Prudential.

Q: How is ICICI Prudential Nifty Pharma ETF taxed?

ICICI Prudential Nifty Pharma ETF is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.

ICICI Prudential Mutual Fund

NAV

₹26.25

+1.91% 1D

as of 27 Oct 2026

Compare SIP calculator

Performance

+1.91%absolute

52-week rangePrev NAV ₹25.76

Latest ₹26.25

Low ₹25.76100th percentile of its 52-week rangeHigh ₹26.25

Key Metrics

Annual fee charged by the fund, already deducted from NAV

—

Category 0.42%

Portfolio-weighted harmonic mean P/E across the fund's equity holdings

—

Category 22.43

Excess return per unit of total volatility (rf = 6.5%)

—

Category 0.24

Scheme Info

Definitions

Plan

—

Period before units can be redeemed — 3 years for ELSS, none for most open-ended funds

—

There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. ntial Nifty Pharma ETF Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/redemption ther

—

Statutory levy on every mutual-fund purchase since 1 Jul 2020 (SEBI / Govt of India) — the same for every scheme

0.005%

SIP Inv.

—

Smallest recurring SIP instalment the scheme accepts

—

Smallest one-time (lumpsum) investment the scheme accepts

₹2,40,000

Nifty Pharma TRI is

Start of our NAV history for this plan. Direct plans begin 1 Jan 2013, so this is the plan's inception — not necessarily the scheme's original launch date.

26 Oct 2026

Period returns (<1Y, absolute — not annualized)

Definitions

Absolute return over the last 1 month (not annualized)

—

Absolute return over the last 3 months (not annualized)

—

Absolute return over the last 6 months (not annualized)

—

Absolute return since 1 Jan of this year (not annualized)

—

Annualized returns (≥1Y — CAGR)

Definitions

1-year point-to-point return, annualized (CAGR)

—

3-year annualized return (CAGR)

—

5-year annualized return (CAGR)

—

10-year annualized return (CAGR)

—

Annualized return (CAGR) since the first NAV we hold for this plan — the Inception date under Key metrics. AMFI's history starts in April 2006, so an older scheme is measured from there.

+1.91%

Advanced metrics — risk and benchmark ratios

Risk (trailing 3Y)

Definitions

Annualized standard deviation of daily returns

—

Excess return per unit of total volatility (rf = 6.5%)

—

Excess return per unit of downside deviation — upside swings aren't penalized (rf = 6.5%)

—

Largest peak-to-trough decline over full history

0.00%

Benchmark ratios (vs Nifty Pharma TRI · 36 monthly returns)

Definitions

Jensen's alpha (annualized): return above what CAPM predicts for the fund's beta vs Nifty Pharma TRI

—

Sensitivity to Nifty Pharma TRI moves; 1 = moves with the index

—

How much of the fund's movement Nifty Pharma TRI explains

—

Excess return per unit of beta (market risk)

—

Active return over the benchmark per unit of tracking error

—

Annualized std dev of fund-minus-benchmark returns

—

Fund's share of benchmark gains in up months (100 = matches index)

—

Fund's share of benchmark losses in down months (lower is better)

—

Computed vs the Nifty Pharma TRI over the last 36 complete months — the closest match to this fund's mandate. TRI means dividends reinvested, as they are in the fund's own NAV; ₹ means a US index converted at each day's USD/INR, since the fund is priced in rupees; price means no free daily yield exists for that index, so the fund's alpha includes roughly the index's dividend yield. Needs ~3 years of history; a low R² means the fund tracks the index loosely.

Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.

Backtest this fund

What a SIP or one-time investment would have grown to over this fund’s real NAV history.

Monthly investment (₹)

Period

Invested

₹10.00K

Current value

₹10.00K

Absolute

0.00%

XIRR

+450.01%

Value vs. invested

ValueInvested

Pick a longer period to plot the path.

1 monthly installments of ₹10,000 into ICICI Prudential Nifty Pharma ETF, valued at the latest NAV. XIRR annualizes for each installment’s timing.

History points

Exit load

Taxation

Taxed as equity

This is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.

Short-term (STCG)

20%

Held under 1 year

Flat, on the whole gain

Long-term (LTCG)

12.5%

Held 1 year or more

On gains above ₹1.25 L per financial year

Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.

Peer comparison · Other ETFs

Compare all


ICICI Prudential Nifty Pharma ETFThis fund ICICI Prudential	—	—	—	—	—	—	—
ICICI Prudential Silver ETF ICICI Prudential	—	+30.61%	+37.98%	—	—	0.40%	₹14,507Cr
HDFC Silver ETF HDFC · Growth	—	+29.98%	+37.93%	—	—	0.50%	₹7,926Cr
Kotak Silver ETF Kotak Mahindra	—	+30.57%	+37.89%	—	—	0.35%	₹3,681Cr
Nippon India Silver ETF Nippon India · Direct · Growth	—	+30.28%	+37.62%	—	—	0.58%	₹31,194Cr
Motilal Oswal Nasdaq Q50 ETF Motilal Oswal	—	+39.37%	+34.62%	—	—	0.57%	₹176.40Cr

AMC Profile

ICICI Prudential Mutual Fund is a joint venture between ICICI Bank and Prudential plc of the UK, in business since 1993. It is among India's largest houses by assets and runs one of the industry's widest scheme line-ups across equity, debt and hybrid.

Launched

11 Oct 1993

Total AUM

₹11,55,871Cr+3.7% QoQ

Avg AUM · July - September 2026

Website

icicipruamc.com

Fund Managers

NPNishit PatelStart date not disclosed

Role

Fund Manager – Passive Funds

Education

Chartered Analyst (CFA) (Level I), Chartered and B.Com

Experience

Mr. Nishit joined ICICI Prudential Asset Management Company Limited in November 2017. He has over 7 years of experience. Past Experience: ~ ICICI Prudential Asset Management Company Limited – ETF Business - November 2017 – January 2020. •

Funds managed (59)

All schemes Nishit Patel runs →

ASAshwini ShindeStart date not disclosed

Role

Manager - Dealer Support

Total experience

Over 6 years

Education

Bachelor of Commerce (B.Com), Master of Commerce (M.Com) from Mumbai University and Inter CA

Experience

During November 2024, Ms. Ashwini was appointed as fund manager for certain passive schemes. Prior to this she was working as the Deputy Manager Dealer Support in the Investment Department of ICICI Prudential Asset Management Company Limited w.e.f. August 1, 2024. Past Experience: ~ ICICI Prudential Asset Management Company Limited - Treasury Mutual Fund Operations - March 14, 2016 to January 30, 2020 ~ ICICI Prudential Asset Management Company Limited - Treasury Mutual ICICI Prudential Nifty IT ETF Fund Operations - August 3, 2021 to July 31, 2024.

Funds managed (58)

All schemes Ashwini Shinde runs →

VAVenus AhujaStart date not disclosed

Role

Dealer – ETF

Total experience

Over 3 years

Education

Chartered Accountant and B.Com

Experience

Ahuja has appointed as the Fund effect from dealer in the Company Asset Company – Investment August 6

Funds managed (35)

All schemes Venus Ahuja runs →

Fund manager, benchmark and dealing terms from this scheme's SEBI-filed Scheme Information Document on AMFI. Each manager's qualifications and role are reconciled across every filing this fund house makes for them, including its Statement of Additional Information. Total AUM via AMFI.

Explore from here

Fund managers

Nishit Patel Ashwini Shinde Venus Ahuja

ICICI Prudential in the news

Headlines about the fund house, not this scheme in particular — highlights only; tap through to read the full story at the source.

Run SIP calculator Add to compare

Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.

About Index funds & ETFs

Index funds and ETFs must keep at least 95% in the securities of the index they track, rather than trying to beat it. They charge far lower fees than active funds, and their return is the index's return minus that small cost and any tracking difference.

Frequently asked questions

What is the NAV of ICICI Prudential Nifty Pharma ETF?

As of 27 Oct 2026, the NAV of ICICI Prudential Nifty Pharma ETF is ₹26.25 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

What returns has ICICI Prudential Nifty Pharma ETF delivered?

ICICI Prudential Nifty Pharma ETF has returned +1.91% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

How risky is ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF sits at the very high level on our estimate of SEBI's risk-o-meter scale and its worst peak-to-trough fall in our sample was 0.0%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

What is the benchmark of ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF is benchmarked against the Nifty Pharma TRI is. The alpha, beta and capture figures on this page are measured against the Nifty Pharma TRI, the closest index whose daily history we hold.

Who manages ICICI Prudential Nifty Pharma ETF?

ICICI Prudential Nifty Pharma ETF is managed by Nishit Patel, Ashwini Shinde and Venus Ahuja at ICICI Prudential.

How is ICICI Prudential Nifty Pharma ETF taxed?

ICICI Prudential Nifty Pharma ETF is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.